We demonstrated substantial morphologic and glycolytic metabolic differences using proton and hyperpolarized 13C magnetic resonance imaging, respectively between and within RCC patient derived xenografts (PDXs). Our findings showed substantial inter-PDX differences in tumor growth rates, as well as the cystic and necrotic components. Furthermore, the xenograft (XEN) established from cell lines derived from the PDX showed significant morphological differences from the parent PDX. Interestingly, upon comparison of two subsequent passages of the same PDX, we found that while the morphological similarities persisted, the glycolytic capacity was significantly increased in the latter passage, implying natural selection of the more aggressive cells.
This abstract and the presentation materials are available to members only; a login is required.